Unleashing the Potential: Hydrogen Market Set to Reach $303.5 Billion by 2032

The Growth of the Hydrogen Market BERLIN, Oct. 17, 2023 (GLOBE NEWSWIRE) — The Hydrogen Market is a fast-growing and transformational industry that is driving the future of sustainable energy. Hydrogen, a versatile and environmentally benign energy carrier, is emerging as an important participant in the global transition to sustainable energy alternatives. It is used…

Read More

Get Ready to Have Your Heart Racing: Cardio Diagnostics Holdings Inc. and Aimil Ltd. Team Up to Bring Cutting-Edge Cardiovascular Epigenetic Tech to India!

We Are Bringing Cardiovascular Health to the Next Level! Exciting News from Cardio Diagnostics Holdings, Inc. Chicago–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced a significant move to transform global cardiovascular health, by entering into a Supply and Distribution Agreement with one of India’s premier…

Read More

Unlocking the Future: Aware Recognized as a Catalyst and Role Model in the Booming Biometrics and Digital Identity Market

Breaking Down Aware’s Designation in the Biometric Digital Identity Market Report What Does It Mean to Be Named a “Catalyst”? According to the latest Biometric Digital Identity Prism Report, Aware, Inc. has been recognized as a true industry “Catalyst” for its disruptive innovations and accelerated growth in the biometrics market. This designation sets Aware apart…

Read More

Unlocking Financial Access: How TessPay’s Fintech Platform is Revolutionizing Funding for All

TessPay Inc. Connecting Households Through the ACP Program– October 17th, 2023 FORT MYERS, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) — TessPay (“the Company”), developer of a supply chain finance financial technology (“FinTech”) platform (the “Platform”) that utilizes blockchain technology to provide payment assurance and liquidity through a supply chain, today announced the introduction of its…

Read More

Charmingly Eccentric: SELLaS Life Sciences Presents Final Data from Phase 1/2 Study of Galinpepimut-S in Combination with Keytruda for Advanced Ovarian Cancer

Charmingly Eccentric: SELLAS Life Sciences Group, Inc. to Present Final Data Exciting News from SELLAS Life Sciences Charmingly eccentric, full of personality, and designed for maximum reader engagement, SELLAS Life Sciences Group, Inc. has announced that they will be presenting the topline clinical data from the final analysis of the Phase 1/2 clinical trial. This…

Read More

Get Ready to Geek Out: Biocytogen and Eucure Biopharma Join Forces to Unleash Exciting Clinical Data for YH003 Anti-CD40 Mab at ESMO 2023!

Delving into the World of Biopharmaceuticals So, you might have heard about Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals making waves in the industry, but what’s all the buzz about? Well, let’s break it down for you in simple terms. What’s the Scoop? Recently, Eucure Biopharma announced its participation in the upcoming ESMO Congress 2023…

Read More